Today: 19 May 2026
XRP stock slides as Senate delays key crypto bill vote; what traders watch next
15 January 2026
1 min read

XRP stock slides as Senate delays key crypto bill vote; what traders watch next

New York, Jan 15, 2026, 13:11 EST — Regular session

  • XRP stock (Bitwise XRP ETF) dropped roughly 3% around midday following the delay of a Senate crypto-bill session
  • The delay also impacted other crypto-related stocks, including Coinbase
  • Traders are focused on when the bill talks will resume and the Senate’s schedule for next week

Shares of the Bitwise XRP ETF—popularly called “XRP stock” among retail investors—dropped 3.2%, slipping to $23.37 in Thursday afternoon trading. The decline followed the U.S. Senate Banking Committee’s decision to delay a key session on a major crypto market-structure bill. Senate Banking Committee

The bill is significant because it aims to clarify which U.S. regulator is responsible for what in crypto markets—a shift investors see as a possible gateway to more institutional interest. When it comes to XRP-related products, the idea of having “rules you can trade around” has come up repeatedly this year. Congress.gov

In the underlying market, XRP — the token — dropped roughly 2.7% in the last 24 hours, trading near $2.08. This kind of move usually filters through swiftly to spot-based funds.

Crypto-linked stocks took a hit as Washington’s delay weighed on the sector. Coinbase Global dropped roughly 3.3%. According to a report, Coinbase withdrew its support for the bill, pointing to concerns over restrictions on stablecoin rewards and new limits affecting tokenized equities and decentralized finance.

The pullback came following a short rally in digital assets earlier this week, driven by traders betting that lawmakers were edging toward a viable regulatory framework.

SEC Chairman Paul Atkins labeled this week as “a big week for crypto” in a post on X and pushed for movement on bipartisan market-structure legislation. X (formerly Twitter)

Not everyone is sold on speed. Lynn Turner, former SEC chief accountant, called the draft “severely deficient” in investor protections in a letter, warning it might open the door to “another FTX-type fraud,” according to a Thomson Reuters Checkpoint News report. Thomson Reuters Tax

Other U.S.-listed XRP funds also slipped in sympathy. The Canary XRP ETF dropped roughly 2.8%, Franklin’s XRP fund lost around 3.2%, Grayscale’s XRP vehicle edged down about 2.8%, and the REX-Osprey XRP ETF fell close to 2.9%.

The Bitwise XRP ETF started trading on NYSE Arca in November, offering investors a way to gain exposure to XRP without owning the token itself.

The downside is clear: should the bill’s compromise collapse—especially over stablecoin yields and DeFi regulation—the legislative timeline could drag out, and the “regulatory clarity” trade might unravel quickly. The committee has pushed back against criticism in its own releases, but the concerns persist. Senate Banking Committee

Traders are now waiting for fresh timing from the Banking Committee, alongside the Senate Agriculture Committee’s scheduled release of its crypto package on Jan. 21. This move could shift expectations once more.

Stock Market Today

  • U.S. Stock Futures Slide on Tech Selloff, War Concerns - May 19, 2026
    May 19, 2026, 8:53 AM EDT. U.S. stock futures declined Tuesday amid another drop in technology shares, dragging the S&P 500 and Nasdaq lower for the second day. Investor sentiment weakened on escalating geopolitical tensions, introducing war uncertainty that added pressure to risk assets. The tech selloff weighed heavily, reflecting ongoing concerns over sector valuations and potential earnings risks. Markets remained cautious as traders balanced these factors against broader economic indicators.

Latest articles

Wellgistics Health Doubles, WGRX Heads Into Key Test

Wellgistics Health Doubles, WGRX Heads Into Key Test

19 May 2026
Wellgistics Health shares fell 21.1% to $0.14 in premarket trading Tuesday after more than doubling Monday. The company delayed its quarterly report, withdrew proxy materials, and is reviewing potential strategic transactions. First-quarter results are due after the market closes. The moves follow a non-binding $15 million acquisition proposal for WellCare Today.
Roblox Stock Moves Up Early, Safety Issues Still Linger

Roblox Stock Moves Up Early, Safety Issues Still Linger

19 May 2026
Roblox shares traded at $47.41 in early New York hours Tuesday, extending gains after third-party data showed a week-over-week rise in concurrent users. Needham maintained its Buy rating and $60 target. The stock remains pressured by a lowered 2026 bookings outlook, tied to new safety and age-check measures. Roblox reported Q1 revenue of $1.4 billion and bookings of $1.7 billion.
Amer Sports Rises Premarket on Salomon Strength

Amer Sports Rises Premarket on Salomon Strength

19 May 2026
Amer Sports raised its 2026 sales, margin, and profit outlook after first-quarter revenue jumped 32% to $1.95 billion, beating forecasts. Shares rose 4.18% in premarket trading to $34.54. Adjusted earnings reached 38 cents a share, above analysts’ estimates. Growth was led by Arc’teryx, Salomon softgoods, and Wilson Tennis 360.

Popular

Micron Stock Is Falling Hard As Samsung’s Strike Fight Tests The AI Memory Boom

Micron Stock Is Falling Hard As Samsung’s Strike Fight Tests The AI Memory Boom

18 May 2026
Micron Technology shares dropped 6.4% to $678.30 by early afternoon Monday, reversing an opening surge and hitting a session low as investors pulled back from semiconductor stocks. The decline followed a 6.6% fall Friday and came amid broader chip sector losses, with the Philadelphia semiconductor index down over 2%. Samsung and its union are set to resume talks Tuesday to avert a strike that could disrupt 3% of global memory-chip output.
Opendoor Technologies stock slips today as mortgage applications surge and Treasuries stay stubborn
Previous Story

Opendoor Technologies stock slips today as mortgage applications surge and Treasuries stay stubborn

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead
Next Story

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead

Go toTop